文献速递脑血管病

追求最佳卒中预防的永恒探索

David G. Sherman Lecture: The Eternal Quest for Optimal Stroke Prevention
RSS 订阅 · Stroke

本文综合近期证据与在研工作,聚焦症状性颈动脉和颅内动脉狭窄的管理证据缺口,以及房颤抗凝治疗质量。文章指出,既往试验显示强化药物治疗可显著降低颅内狭窄患者的复发血管事件,而数十年前的颈动脉狭窄试验已不能反映现代药物能力。同时,美国房颤相关卒中持续上升,未充分治疗的房颤所致大血管闭塞性卒中是可预防的疾病负担。

要点

  • 强化、方案驱动的药物治疗可显著减少颅内动脉狭窄患者的复发血管事件。
  • 颈动脉狭窄治疗决策不能仅依据狭窄程度,应整合磁共振斑块内出血等影像标志物。
  • 未充分治疗的房颤所致大血管闭塞性卒中是可预防的卫生系统负担。

核心结论

  • 以患者为中心的精准卒中预防需要当代前瞻性数据、先进血管影像生物标志物的整合,以及对房颤患者预防性治疗的系统性改进。

研究设计与样本

  • 本文为叙述性综述,综合卒中预防领域近期证据与在研工作,聚焦颈动脉和颅内动脉狭窄以及房颤抗凝治疗。

主要发现

  • 既往针对颅内动脉狭窄的试验证实,积极的、方案驱动的药物治疗可大幅降低复发血管事件。
  • 三十多年前开展的颈动脉狭窄里程碑试验已不能反映现代药物能力。
  • 磁共振斑块内出血等斑块影像证据提示,仅凭狭窄程度不足以确定治疗策略。
  • 受人口老龄化驱动,美国房颤相关卒中持续上升,未充分治疗的房颤所致大血管闭塞性卒中是可预防的负担。

临床怎么用

  • 在症状性颈动脉和颅内动脉狭窄管理中,应考虑当代强化药物治疗相对于介入治疗的价值。
  • 在颈动脉狭窄评估中整合磁共振斑块内出血等先进血管影像生物标志物,而非仅依赖狭窄程度。
  • 系统性改进房颤患者抗凝治疗质量,以减少可预防的大血管闭塞性卒中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stroke, Volume 57, Issue 10, Page 3195-3199, October 1, 2026. Despite decades of clinical trial activity in stroke prevention, critical gaps remain in the evidence base guiding management of symptomatic carotid and intracranial stenosis and the quality of anticoagulation care delivered to patients with atrial fibrillation (AF). This article synthesizes recent evidence and ongoing research efforts addressing 2 enduring challenges: demonstrating the value of intensive medical therapy relative to interventional approaches and improving the quality of stroke prevention care in AF. Previous trials focused on intracranial stenosis established that aggressive, protocol-driven medical management substantially reduces recurrent vascular events. In the realm of carotid stenosis, landmark trials conducted >3 decades ago no longer reflect modern pharmacological capabilities. Emerging evidence from plaque imaging, particularly intraplaque hemorrhage on magnetic resonance imaging, suggests that stenosis severity alone is an insufficient determinant of treatment strategy. Simultaneously, strokes related to AF continue to rise in the United States, driven by demographic aging, and large vessel occlusion strokes attributable to undertreated AF represent a preventable burden on the health system. Patient-centered, precision stroke prevention requires contemporary prospective data, integration of advanced vascular imaging biomarkers, and systematic improvements in preventative therapies for patients with AF. Targeting these areas holds promise for improving stroke prevention in the coming decades.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Stroke:David G. Sherman Lecture: The Eternal Quest for Optimal Stroke Prevention

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。